REFERENCES
- Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S. History of the methamphetamine problem. J Psychoactive Drugs. 2000; 32: 137–141. [PUBMED], [INFOTRIEVE]
- Diagnostic and Statistical Manual, 4th ed., Washington, DC, American Psychiatric Association. 1994
- Gawin FH, Ellinwood EH, Jr.. Cocaine and other stimulants: actions, abuse, and treatment. N Engl J Med. 1988; 318: 1173–1182. [PUBMED], [INFOTRIEVE]
- Cottier LB, Shillington AM, Compton WM, Mager D, Spitznagel EL.. Subjective reports of withdrawal among cocaine users: recommendations for DSM-IV. Drug Alcohol Depend. 1993; 33: 97–104. [CROSSREF]
- Weddington WW, Brown BS, Haertzen CA, et al, Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts: a controlled, residential study. Arch Gen Psychiatry. 1990; 47: 861–868. [PUBMED], [INFOTRIEVE]
- Kampman KM, Volpicelli JR, McGinnis DE, et al, Reliability and validity of the Cocaine Selective Severity Assessment. Addict Behav. 1998; 23: 449–461. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Coffey SF, Dansky BS, Carrigan MH, Brady KT. Acute and protracted cocaine abstinence in an outpatient population: a prospective study of mood, sleep and withdrawal symptoms. Drug Alcohol Depend. 2000; 59: 277–286. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Cantwell B, McBride AJ. Self-detoxification by amphetamine-dependent patients: a pilot study. Drug Alcohol Depend. 1998; 49: 157–163. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Churchill AC, Burgess PM, Pead J, Gill T. Measurement of the severity of amphetamine dependence. Addiction. 1993; 88: 1335–1340. [PUBMED], [INFOTRIEVE]
- Srisurapanont M, Jarusuraisin N, Jittiwutikan J. Amphetamine withdrawal: I. Reliability, validity and factor structure of a measure. Aust N Z J Psychiatry. 1999; 33: 89–93. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Srisurapanont M, Jarusuraisin N, Jittiwutikan J.. Amphetamine withdrawal: II. A placebo-controlled, randomised, double-blind study of amineptine treatment. Aust N Z J Psychiatry. 1999; 33: 94–98. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Beck AT, Ward CH, Mendelson J, Mock J, Erbaugh J. The Beck Depression Inventory. Arch Gen Psychiatry. 1968; 4: 561–571
- Spitzer R, Williams J, Gibbon M. Structured Clinical Interview for DSM-IV (SCID). New York, New York State Psychiatric Institute, Biometrics Research. 1995
- McLellan AT, Luborsky L, Cacciola J, et al, Guide to the addiction severity index background, administration, and field testing results. Pub No. Adm88. Washington, DC, U.S. Government Printing Office. 1988
- Nelson HE. National Adult Reading Test (NART): Test Manual. WindsorUK, NFER Nelson. 1982
- Kalechstein AD, Newton TF, Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci. 2003; 15: 215–220. [PUBMED], [INFOTRIEVE]
- Keppel G. Design and Analysis: A Researcher's Handbook. Englewood Cliffs, NJ, Prentice Hall. 1982
- Spreen O, Strauss E. A Compendium of Neuropsychological Tests Administration, Norms, and Commentary. New York, Oxford University Press. 1998
- Villemagne V, Yuan J, Wong DF, et al, Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations. J Neurosci. 1998; 18: 419–427. [PUBMED], [INFOTRIEVE]
- Melega WP, Lacan G, Harvey DC, Huang SC, Phelps ME. Dizocilpine and reduced body temperature do not prevent methamphetamine-induced neurotoxicity in the vervet monkey: [11CJWIN 35,428 - positron emission tomography studies. Neurosci Lett. 1998; 258: 17–20. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Ricaurte GA, Schuster CR, Seiden LS. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res. 1980; 193: 153–163. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Little KY, Zhang L, Desmond T, et al, Striatal dopaminergic abnormalities in human cocaine users. Am J Psychiatry. 1999; 156: 238–245. [PUBMED], [INFOTRIEVE]
- Levy ML, Cummings JL, Fairbanks LA, et al, Apathy is not depression. J Neuropsychiatry Clin Neurosci. 1998; 10: 314–319. [PUBMED], [INFOTRIEVE]
- Volkow ND, Chang L, Wang GJ, et al, Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci. 2001; 21: 9414–9418. [PUBMED], [INFOTRIEVE]
- McCann UD, Wong DF, Yokoi F, et al, Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J Neurosci. 1998; 18: 8417–8422. [PUBMED], [INFOTRIEVE]
- Wilson JM, Kalasinsky KS, Levey AI, et al, Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med. 1996; 2: 699–703. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Melega WP, Raleigh MJ, Stout DB, et al, Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey. Brain Res. 1997; 766: 113–120. [CROSSREF], [CROSSREF], [PUBMED], [INFOTRIEVE]
- Kalechstein AD, Newton TF, Longshore D, et al, Psychiatric comorbidity of methamphetamine dependence in a forensic sample. J Neuropsychiatry Clin Neurosci. 2000; 12: 480–484. [PUBMED], [INFOTRIEVE]